GSK
GSK’s tuberculosis vaccine shows efficacy over three years in HIV negative patients
October 29, 2019Manufacturing and Production, Research and Development GSK, IAVI, Vaccine, pharma, tuberculosis
Promising results have been revealed from a GlaxoSmithKline study, conducted in partnership with non-profit scientific research organisation IAVI, investigating the …
GSK Chief Emma Walmsley voices support for equal pay campaign
October 3, 2019Medical Communications Emma Walmsley, GSK, GlaxoSmithKline, pharma
GlaxoSmithKline Chief Emma Walmsley has joined the chorus of more than a hundred of the UK’s most successful female business …
GSK’s Zejula slows disease progression in a range of ovarian cancers
October 2, 2019Research and Development Cancer, ESMO 2019, GSK, Zejula, ovarian cancer, pharma
At the 2019 European Society for Medical Oncology (ESMO) congress, GlaxoSmithKline unveiled new Phase 3 data on Zejula (niraparib) for …
GlaxoSmithKline acquires Sitari Pharmaceuticals after progress in coeliac disease
September 11, 2019Research and Development, Sales and Marketing Avalon Ventures, GSK, coeliac disease
Avalon Ventures has announced that it has entered into a definitive agreement with GSK for the acquisition of Sitari Pharmaceuticals …
Four perspectives from life sciences companies on multichannel engagement
August 23, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Biogen, GSK, Lifesciences, Teva, healthcare, pharma
By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in …
GSK’s two drug HIV regimen effective when administered every two months
August 22, 2019Research and Development AIDS, GSK, HIV, ViiV Healthcare, viral supression
GSK’s long-acting, two-drug HIV regimen was as effective in supressing patient’s viral loads when administered every two months (eight weeks), …
European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma
August 2, 2019Medical Communications, Sales and Marketing Europe, GSK, Nucala, asthma, pharma
Following closely on the heels of the news that its deal to merge Pfizer’s consumer health business with its own, …
GSK closes the deal with Pfizer over $9.8 billion consumer healthcare merger
August 1, 2019Sales and Marketing GSK, Pfizer, merger, pharma
The $9.8 billion joint venture between major pharma firms GlaxoSmithKline and Pfizer to merge their consumer health operations has come …
GSK teams up with Strathclyde and University of Nottingham
July 16, 2019Manufacturing and Production GSK, GlaxoSmithKline, UK, britain, pharma, universities
GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at …
Top Ten most popular articles on Pharmafile.com this week!
July 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines
This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …
ViiV Healthcare’s two drug HIV therapy beats Gilead’s three drug treatment in Phase 3 trial
July 10, 2019Research and Development AIDS, Dovato, GSK, Gilead, HIV, ViiV, pharma
Pfizer and GlaxoSmithKline’s HIV company, ViiV Healthcare, has said its two-drug combo Dovato (dolutegravir and lamuvidine) met its primary endpoint …
ViiV’s Dovato approved in Europe as treatment option for HIV-1
July 3, 2019Research and Development, Sales and Marketing Dovato, GSK, HIV, ViiV Healthcare, pharma
ViiV Healthcare, the specialist HIV firm majority owned by GSK, is celebrating the news that the European Commission has chosen …
Top Ten most popular articles on Pharmafile.com this week
June 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit
This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …
Top Ten most popular articles on Pharmafile.com this week
June 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, MSD, Parkinson's, blockchain, brexit, top ten
It’s Friday, and time for another run-down of the week’s most popular articles.
GSK offers concessions ahead of planned venture with Pfizer
June 21, 2019Medical Communications, Sales and Marketing GSK, Pfizer, pharma
The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinational’s planned joint …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
